Skip to content

Effect of transcranial magnetic stimulation in post stroke spasticity in acute stroke

TO Evaluate the effectiveness Of repetitive Transcranial magnetic stimulation(rTMS) in Prevention Of Post-stroke Spasticity in acute stroke -an open label randomized sham control trail - RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/061225
Enrollment
70
Registered
2024-01-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G988- Other disorders of nervous system

Interventions

Intervention1: REPITITIVE TRANSCRANIAL MAGNETIC STIMULATION: The treatment arm will consist of 3 consecutive daily treatment sessions. One treatment session in this study with real rTMS will consist o

Sponsors

AIIMS Bhubaneswar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. First-time stroke 2. Stroke with in 7 to 30days 3. 18 years of age or older 4. Gender- either male or female 5. Ability to follow three-step directions 6. patients with no spasticity or minimal spasticity 7. Sufficient ambulation or wheelchair mobility to allow subject to present to treatment and testing areas with minimum assist

Exclusion criteria

Exclusion criteria: 1. History of seizure within the past two years 2. Inability to follow three-step directions 3. Anosognosia 4. Moderate to severe receptive aphasia 5. Premorbid spasticity or neurologic impairment prior to stroke 6. Co-morbidities impairing upper extremity function such as fracture or deformity 7. Indwelling metal or medical devices incompatible with TMS 8. Pregnancy 9. Bi-hemispheric or multifocal stroke 10. Severe dementia 11. Neurolytic injection within the 3 months prior to onset of study or planned neurolytic injection during study period

Design outcomes

Primary

MeasureTime frame
Change in Baseline modified Modified Ashworth Scale score from Day 1 (Pre-treatment) to Day 5 (Post-treatment),at 1monthTimepoint: Change in modified Modified Ashworth Scale score at baseline,at 4weeks and 12weeks.

Secondary

MeasureTime frame
1.Motor function improvement will be assessed through digital hand dynamometer. 2.Change in Baseline Corticospinal Excitability Measures from Day 1 (Pre-treatment) to Day 5 (Post- treatment). Corticospinal excitability measures used will include threshold & motor evoked potential (MEP) amplitude & cortical silent period duration.Timepoint: at baseline,4weeks & at 12weeks

Countries

India

Contacts

Public ContactDr sanjeev kumar Bhoi

AIIMS BHUBANESWAR

bhoisanjeev@gmail.com9919787978

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026